Related Experiment Video
Updated: Aug 8, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
Patient and caregiver time burden associated with anaemia treatment in different patient populations
Arthur C Houts1, Geoffrey A Loh, Barry V Fortner
1Supportive Oncology Services and Accelerated Community Oncology, Memphis, TN 38138, USA. ahouts@sosacorn.com
Goals:
Cancer patients treated with chemotherapy often develop anaemia. This cross-sectional analysis examined the effect of anaemia treatment on patient and caregiver time and activities.
Materials And Methods:
The analysis included 9,920 patients from 646 US outpatient oncology centres. Patients completed a survey that contained questions about travel time, total time for the visit and other impacts.
Results:
The mean time taken for a single clinic visit to receive anaemia treatment was 2.2 h. On average, patients receiving epoetin alfa required 17.6 h more than patients receiving darbepoetin alfa to complete a course of anaemia treatment. All patients in the study reported that they had to adjust at least one activity as a result of clinic visits. Older patients, women and patients from low-income areas were more likely to be accompanied during clinic visits.
Conclusions:
Reducing the number of clinic visits needed for anaemia treatment by using darbepoetin alfa may benefit patients.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Heart Failure VI: Adjunct Therapies
Venous Thrombosis IV: Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Kidney Transplant III: Nursing Management
Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data from the...
